Vor Bio Reports Inducement Grants to Newly Hired Employees Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio announced the grant of stock options and RSUs to 9 newly hired employees, totaling 42,650 shares and 9,050 shares, respectively. The options have a ten-year term and an exercise price of $17.39 per share, while the RSUs will vest over a four-year period. The grants were made as inducements to employment under Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan.